Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

c-Rel anticorps (AA 453-464)

c-Rel Reactivité: Humain WB, ELISA, IHC, IHC (p) Hôte: Chèvre Polyclonal unconjugated
N° du produit ABIN962681
  • Antigène Voir toutes c-Rel Anticorps
    c-Rel (REL proto-oncogene (c-Rel))
    Épitope
    • 19
    • 9
    • 8
    • 7
    • 7
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 453-464
    Reactivité
    • 85
    • 23
    • 6
    • 5
    • 5
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 78
    • 10
    • 1
    Chèvre
    Clonalité
    • 71
    • 18
    Polyclonal
    Conjugué
    • 37
    • 9
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp c-Rel est non-conjugé
    Application
    • 60
    • 37
    • 13
    • 13
    • 10
    • 9
    • 5
    • 4
    • 3
    • 3
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Marque
    IHC-plus™
    Specificité
    Human REL / c-Rel.
    Homologie
    Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Orangutan, Gibbon, Monkey (100%) Marmoset, Panda, Dog, Bat, Horse, Pig (92%) Bovine, Rabbit (83%).
    Purification
    Immunoaffinity purified
    Immunogène
    Synthetic peptide NDLNASNACIYN from an internal region of human REL / c-Rel (NP_002899.1). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Orangutan, Gibbon, Monkey (100%), Marmoset, Panda, Dog, Bat, Horse, Pig (92%), Bovine, Rabbit (83%).

    Type of Immunogen: Synthetic peptide
    Top Product
    Discover our top product c-Rel Anticorps primaire
  • Indications d'application
    Approved: IHC, IHC-P (2.5 - 3.75 μg/mL), Peptide-ELISA (1:16000), WB (0.5 - 2 μg/mL)

    Usage: Peptide ELISA: antibody detection limit dilution 1:16000. Western blot: Approx 70  kDa band observed in Human Spleen and Human Peripheral Blood Mononucleocytes lysates (calculated MW of 68.5  kDa according to NP_002899.1). Recommended concentration: 0.5-2 μg/mL.
    Commentaires

    Target Species of Antibody: Human

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    Tris-buffered saline,  pH 7.3, 0.5 % BSA, 0.02 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Minimize freezing and thawing.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Avoid freeze-thaw cycles.
  • Antigène
    c-Rel (REL proto-oncogene (c-Rel))
    Autre désignation
    REL / C-Rel (c-Rel Produits)
    Synonymes
    anticorps C-Rel, anticorps c-Rel, anticorps NFkB, anticorps c-rel, anticorps zgc:100833, anticorps Xrel2, anticorps Xrel3, anticorps rel, anticorps rel-A, anticorps rel2, anticorps rel3, anticorps v-rel, anticorps xrel, anticorps REL proto-oncogene, NF-kB subunit, anticorps reticuloendotheliosis oncogene, anticorps RELA proto-oncogene, NF-kB subunit, anticorps v-rel avian reticuloendotheliosis viral oncogene homolog, anticorps v-rel avian reticuloendotheliosis viral oncogene homolog L homeolog, anticorps ribonuclease A family member 2 pseudogene, anticorps REL, anticorps Rel, anticorps Rela, anticorps rel, anticorps rel.L, anticorps ECRP
    Sujet
    Name/Gene ID: REL

    Synonyms: REL, C-Rel, C-Rel proto-oncogene protein, I-Rel, Proto-oncogene c-Rel
    ID gène
    5966
    NCBI Accession
    NP_002899
    UniProt
    Q04864
Vous êtes ici:
Support technique